Category : Healthcare and Pharmaceutical

Public Health, Disease Prevention & Wellness

ERA Congress: Long-Term Data Show Zigakibart’s Efficacy in IgA Nephropathy

PR Newswire
by PR Newswire0174
New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as a disease-modifying treatment for IgA nephropathy...
Healthcare Quality, Patient Safety & Policy

Innovent & HUTCHMED NDA Accepted for Sintilimab Combo in China

PR Newswire
by PR Newswire0178
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...
Healthcare Quality, Patient Safety & Policy

Akeso’s Cadonilimab Approved for 1st-Line Cervical Cancer Treatment

PR Newswire
by PR Newswire0184
Akeso, Inc. is pleased to announce that the National Medical Products Administration (NMPA) has approved the company’s first- in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, for the first-line...
Digital Health, Technology & Innovation

MGI Tech Expands Fiocruz Partnership to Boost Brazil Health Advances

PR Newswire
by PR Newswire0149
Next-generation technologies will help increase the agility and efficiency of genetic sequencing to tackle several diseases MGI Tech Co., Ltd., a company committed to building...
Healthcare Infrastructure, Operations & Supply Chain

Agenus, Zydus in $141M Deal to Boost US Biologics Manufacturing

Business Wire
by Business Wire0180
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifesciences Ltd. (NSE: ZYDUSLIFE), including its...
Digital Health, Technology & Innovation

Aizon, Sequence Partner to Transform Biopharma with AI

Business Wire
by Business Wire0191
Aizon and Sequence are pleased to announce a new strategic partnership aimed at delivering comprehensive, AI-powered solutions for the pharmaceutical industry. This collaboration will combine...
Clinical Research, Pharma & Healthcare Financing

Fujirebio Launches Lumipulse G sTREM2 Neuro Test for Research

Business Wire
by Business Wire0203
H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G sTREM2 assay for the fully automated LUMIPULSE® G...
Clinical Research, Pharma & Healthcare Financing

Pacific Prime Supports Children’s Heart Care with Rende Fund

Business Wire
by Business Wire0175
Pacific Prime, a global health insurance intermediary group in international health insurance and employee benefits solutions, is proud to announce that two children with heart disease, financially assisted by...
Clinical Research, Pharma & Healthcare Financing

XellSmart Gets FDA Clearance for 3 Phase I INDs in CNS Cell Therapies

PR Newswire
by PR Newswire0183
XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell therapies. To date, the company has...
Healthcare Quality, Patient Safety & Policy

Asgard Therapeutics Adds Top Experts to Board, Boosting Drug & Cancer Immunotherapy

PR Newswire
by PR Newswire0182
Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announces the appointments of Dr Cristina Csimma as an independent member of...
Healthcare Quality, Patient Safety & Policy

6th Global Pharma Picks LifeSphere NavaX for GenAI Case Processing

PR Newswire
by PR Newswire0191
Top 25 Global Life Science Organization Adopts NavaX, Demonstrating Industry Confidence in Scalable, GenAI-Enabled Technologies ArisGlobal, an innovative technology company at the forefront of life...